TP53 and neoplasm: Current evidence supports that TP53 (the tumor suppressor) gene therapy aids in the success of conventional chemotherapy, most of which leads to DNA damage, exerting persistent anti-tumor efficacies via p53-mediated apoptotic process and impediment of cell proliferating [27–30].